Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

NCT00003056 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

105

Enrollment

INDUSTRY

Sponsor class

Stopped Interim analysis indicated study should be terminated

Conditions

Leukemia
Lymphoma
Graft Versus Host Disease

Interventions

DRUG: cyclosporine
DRUG: cyclosporine and methotrexate

Sponsor

Baxalta now part of Shire